Related content

Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry

By Strobbe Leonie   van der Schans Saskia A. M.   Heijker Sanneke   Meijer Jos W. R.   Mattijssen E. J. M. Vera   Mandigers Carolien M. P. W.   de Kievit Ineke M.   Raemaekers John M. M.   Hebeda Konnie M.   van Krieken J. Han J. M.  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1018-1022

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas

By Celik I.   Kars A.   Guler N.   Barista I.   Tekuzman G.   Ozyilkan O.   Hayran M.   Firat D.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 759-760

Elsevier

Access to resources Recommend Favorite

The Follicular Non-Hodgkin's Lymphomas--I. The Possibility of Cure

By Denham J.W.   Denham E.   Dear K.B.   Hudson G.V.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 470-479

Elsevier

Access to resources Recommend Favorite

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas

By El-Helw Loaie M   Hancock Barry W  

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 445-453

Future Medicine

Access to resources Recommend Favorite

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas

By Bezwoda W.   Rastogi R.B.   Erazo Valla A.   Diaz-Maqueo J.C.   Pavlovsky S.   Morioka H.   Resegotti L.   Rueckle H.   Somoza N.   Moreno-Nogueira J.A.   Bernasconi C.   Ho A.   Burns I.   Lardinois J.   van der Merwe A.   Richards E.   Novantrone International Study Group  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 903-911

Elsevier

Access to resources Recommend Favorite